These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9417013)
21. Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia. Goldsmith DR; Plosker GL Drugs; 2005; 65(14):2037-47. PubMed ID: 16162024 [TBL] [Abstract][Full Text] [Related]
22. Terazosin vs finasteride for BPH. Zacks M J Fam Pract; 1996 Dec; 43(6):533. PubMed ID: 8969692 [No Abstract] [Full Text] [Related]
23. Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia. Ohsfeldt RL; Kreder KJ; Klein RW; Chrischilles EA J Manag Care Pharm; 2004; 10(5):412-22. PubMed ID: 15369424 [TBL] [Abstract][Full Text] [Related]
24. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach]. Jolliet P; Bourin M Therapie; 1998; 53(1):61-6. PubMed ID: 9773101 [TBL] [Abstract][Full Text] [Related]
25. The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Gonzalez CM; McVary KT Curr Urol Rep; 2003 Aug; 4(4):276-81. PubMed ID: 12882718 [No Abstract] [Full Text] [Related]
27. [Experience in the use of doxazosin in patients with benign hyperplasia of the prostate]. Lopatkin NA; Loran OB; Pushkar' DIu; Perepanova TS; Tevlin KP Urol Nefrol (Mosk); 1998; (3):3-5. PubMed ID: 9644978 [TBL] [Abstract][Full Text] [Related]
29. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia]. Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199 [TBL] [Abstract][Full Text] [Related]
31. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study? Cheng TO Int J Cardiol; 2006 Feb; 107(2):275-6. PubMed ID: 16412808 [No Abstract] [Full Text] [Related]
32. [The objective of medical treatment: relieve the symptoms or stop the course?]. Desgrandchamps F Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585 [No Abstract] [Full Text] [Related]
33. Treatment of benign prostatic hyperplasia. Walsh PC N Engl J Med; 1996 Aug; 335(8):586-7. PubMed ID: 8678937 [No Abstract] [Full Text] [Related]
34. Breakthrough treatment for prostate enlargement. Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965 [No Abstract] [Full Text] [Related]
36. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. Johnson TM; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667 [TBL] [Abstract][Full Text] [Related]